Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Dow Inc. stock logo
DOW
DOW
$22.18
+1.2%
$23.40
$20.40
$53.48
$15.54B0.8813.71 million shs10.59 million shs
Ethan Allen Interiors Inc. stock logo
ETD
Ethan Allen Interiors
$28.05
+0.2%
$29.19
$24.55
$32.61
$712.50M1.12264,571 shs191,026 shs
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$118.30
-0.2%
$115.00
$85.60
$121.83
$147.01B0.347.87 million shs4.55 million shs
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Dow Inc. stock logo
DOW
DOW
+1.19%-1.89%-8.19%-22.08%-57.80%
Ethan Allen Interiors Inc. stock logo
ETD
Ethan Allen Interiors
-0.13%-0.23%-4.86%-3.96%-7.38%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
-0.15%+0.04%+5.12%+8.73%+37.85%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Dow Inc. stock logo
DOW
DOW
$22.18
+1.2%
$23.40
$20.40
$53.48
$15.54B0.8813.71 million shs10.59 million shs
Ethan Allen Interiors Inc. stock logo
ETD
Ethan Allen Interiors
$28.05
+0.2%
$29.19
$24.55
$32.61
$712.50M1.12264,571 shs191,026 shs
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$118.30
-0.2%
$115.00
$85.60
$121.83
$147.01B0.347.87 million shs4.55 million shs
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Dow Inc. stock logo
DOW
DOW
+1.19%-1.89%-8.19%-22.08%-57.80%
Ethan Allen Interiors Inc. stock logo
ETD
Ethan Allen Interiors
-0.13%-0.23%-4.86%-3.96%-7.38%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
-0.15%+0.04%+5.12%+8.73%+37.85%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Dow Inc. stock logo
DOW
DOW
2.10
Hold$29.6333.58% Upside
Ethan Allen Interiors Inc. stock logo
ETD
Ethan Allen Interiors
2.00
Hold$30.006.97% Upside
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
2.86
Moderate Buy$118.08-0.18% Downside

Current Analyst Ratings Breakdown

Latest GILD, DOW, and ETD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/14/2025
Dow Inc. stock logo
DOW
DOW
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSector Perform$24.00
10/14/2025
Dow Inc. stock logo
DOW
DOW
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D+)
10/14/2025
Dow Inc. stock logo
DOW
DOW
Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetNeutral$25.00 ➝ $24.00
10/9/2025
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$129.00 ➝ $135.00
10/8/2025
Dow Inc. stock logo
DOW
DOW
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D+)
10/8/2025
Ethan Allen Interiors Inc. stock logo
ETD
Ethan Allen Interiors
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C+)
10/8/2025
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy (B)
10/8/2025
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetSector Perform$98.00 ➝ $100.00
10/8/2025
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$125.00 ➝ $135.00
10/6/2025
Dow Inc. stock logo
DOW
DOW
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$23.00 ➝ $24.00
10/3/2025
Dow Inc. stock logo
DOW
DOW
Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetNeutral$30.00 ➝ $26.00
(Data available from 10/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Dow Inc. stock logo
DOW
DOW
$42.96B0.37$5.90 per share3.76$25.36 per share0.87
Ethan Allen Interiors Inc. stock logo
ETD
Ethan Allen Interiors
$614.65M1.16$2.67 per share10.50$18.97 per share1.48
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$28.86B5.09$6.86 per share17.25$15.44 per share7.66
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Dow Inc. stock logo
DOW
DOW
$1.12B-$1.40N/A7.62N/A-2.35%0.31%0.10%10/23/2025 (Estimated)
Ethan Allen Interiors Inc. stock logo
ETD
Ethan Allen Interiors
$51.60M$2.0113.9510.87N/A8.39%10.92%7.10%10/29/2025 (Estimated)
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$480M$5.0223.5714.590.8121.86%50.99%17.24%10/30/2025 (Estimated)

Latest GILD, DOW, and ETD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/30/2025Q3 2025
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$2.16N/AN/AN/A$7.42 billionN/A
10/29/2025Q1 2026
Ethan Allen Interiors Inc. stock logo
ETD
Ethan Allen Interiors
$0.44N/AN/AN/A$149.15 millionN/A
10/23/2025Q3 2025
Dow Inc. stock logo
DOW
DOW
-$0.27N/AN/AN/A$10.19 billionN/A
8/7/2025Q2 2025
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$1.96$2.01+$0.05$1.55$6.95 billion$7.08 billion
7/30/2025Q4 2025
Ethan Allen Interiors Inc. stock logo
ETD
Ethan Allen Interiors
$0.45$0.49+$0.04$0.48$152.20 million$160.36 million
7/24/2025Q2 2025
Dow Inc. stock logo
DOW
DOW
-$0.11-$0.42-$0.31-$1.18$10.38 billion$10.10 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Dow Inc. stock logo
DOW
DOW
$1.406.31%N/AN/A N/A
Ethan Allen Interiors Inc. stock logo
ETD
Ethan Allen Interiors
$1.565.56%N/A77.61%1 Years
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$3.162.67%N/A62.95%10 Years

Latest GILD, DOW, and ETD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/9/2025
Dow Inc. stock logo
DOW
DOW
quarterly$0.356.35%11/28/202511/28/202512/12/2025
7/29/2025
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
quarterly$0.792.81%9/15/20259/15/20259/29/2025
7/24/2025
Dow Inc. stock logo
DOW
DOW
quarterly$0.355.69%8/29/20258/29/20259/12/2025
7/29/2025
Ethan Allen Interiors Inc. stock logo
ETD
Ethan Allen Interiors
quarterly$0.395.3%8/13/20258/13/20258/28/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Dow Inc. stock logo
DOW
DOW
0.87
1.69
1.05
Ethan Allen Interiors Inc. stock logo
ETD
Ethan Allen Interiors
N/A
2.03
1.11
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
1.13
1.32
1.15

Institutional Ownership

CompanyInstitutional Ownership
Dow Inc. stock logo
DOW
DOW
64.00%
Ethan Allen Interiors Inc. stock logo
ETD
Ethan Allen Interiors
83.80%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
83.67%

Insider Ownership

CompanyInsider Ownership
Dow Inc. stock logo
DOW
DOW
0.50%
Ethan Allen Interiors Inc. stock logo
ETD
Ethan Allen Interiors
9.92%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
0.27%
CompanyEmployeesShares OutstandingFree FloatOptionable
Dow Inc. stock logo
DOW
DOW
36,000708.84 million705.30 millionOptionable
Ethan Allen Interiors Inc. stock logo
ETD
Ethan Allen Interiors
3,21125.45 million22.92 millionOptionable
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
17,6001.24 billion1.24 billionOptionable

Recent News About These Companies

Gilead highlights HIV pipeline at European AIDS Conference
Gilead and Arcus see survival boost with gastric cancer combo
Gilead Sciences, Inc. $GILD Shares Sold by IFP Advisors Inc

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
DOW stock logo

DOW NYSE:DOW

$22.18 +0.26 (+1.20%)
Closing price 10/15/2025 03:59 PM Eastern
Extended Trading
$22.30 +0.12 (+0.55%)
As of 09:06 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Dow, Inc. is a materials science company, which engages in the development of innovative solutions. It operates through the following segments: Packaging and Specialty Plastics, Industrial Intermediates and Infrastructure, and Performance Materials and Coatings. The Packaging and Specialty Plastics segment consists of hydrocarbons and energy and packaging and specialty plastics. The Industrial Intermediates and Infrastructure segment covers the industrial solutions and polyurethanes and construction chemicals. The Performance Materials and Coatings segment includes coatings and performance monomers and consumer solutions. The company was founded in 1897 and is headquartered in Midland, MI.

Ethan Allen Interiors stock logo

Ethan Allen Interiors NYSE:ETD

$28.04 +0.05 (+0.16%)
Closing price 10/15/2025 03:59 PM Eastern
Extended Trading
$28.08 +0.03 (+0.12%)
As of 05:35 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ethan Allen Interiors Inc. operates as an interior design company, and manufacturer and retailer of home furnishings in the United States, Mexico, Honduras, and Canada. The company operates in two segments, Wholesale and Retail. Its products include case goods items, such as beds, dressers, armoires, tables, chairs, buffets, entertainment units, home office furniture, and wooden accents; upholstery comprising fabric-covered items, such as sleepers, recliners and other motion furniture, chairs, ottomans, custom pillows, sofas, loveseats, cut fabrics, and leather; and home accent items consisting of window treatments and drapery hardware, wall decors, florals, lighting, clocks, mattresses, bedspreads, throws, pillows, decorative accents, area rugs, wall coverings, and home and garden furnishings. The company markets and sells its products under the Ethan Allen brand through home furnishing retail networks and independent retailers, as well as through ethanallen.com website. It operates a network of design centers. Ethan Allen Interiors Inc. was founded in 1932 and is headquartered in Danbury, Connecticut.

Gilead Sciences stock logo

Gilead Sciences NASDAQ:GILD

$118.30 -0.18 (-0.15%)
Closing price 10/15/2025 04:00 PM Eastern
Extended Trading
$118.18 -0.11 (-0.10%)
As of 08:59 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.